Stay updated on Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on the page, indicating a newer build of the Study Details page. The update does not change the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-07-05T11:16:28.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2, indicating a page/template update. No study content, eligibility criteria, or results appear to be affected.
    Difference
    0.0%
    Check dated 2026-06-28T08:30:22.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows that no participants are being recruited and adds user-focused sections such as How to Read a Study Record, Common Questions, and How to Join a Study, while updating the Intervention/Treatment heading formatting.
    Difference
    0.4%
    Check dated 2026-06-13T17:35:47.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label at the bottom of the page changed from v3.5.4 to v3.5.5, reflecting a small update to the page.
    Difference
    0.0%
    Check dated 2026-06-06T14:27:35.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now listed, replacing the previous v3.5.3, indicating a new version of the related document or protocol.
    Difference
    0.0%
    Check dated 2026-05-15T23:44:59.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:28:57.000Z thumbnail image

Stay in the know with updates to Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.